Advertisement

Topics

Portola shares soar after FDA approves clot preventing drug

11:20 EDT 23 Jun 2017 | Reuters

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surger...

Original Article: Portola shares soar after FDA approves clot preventing drug

NEXT ARTICLE

More From BioPortfolio on "Portola shares soar after FDA approves clot preventing drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...